References
- 1. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (Eds.). American Joint Committee on Cancer (AJCC) Cancer Staging Manual. 7th ed. New York: Springer; 2009.
- 2. Sobin LH, Gospodarowicz MK, Wittekind Ch, eds. International Union Against Cancer (UICC) TNM Classification of Malignant Tumors. 7th ed. Oxford, UK: Wiley-Blackwell; 2009.
- 3. Nelson H, Petrelli N, Carlin A, Couture J, Fleshman J, Guillem J, et al. Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst. 2001; 93:583-96.10.1093/jnci/93.8.583
- 4. Washington MK, Berlin J, Branton P, Burgart LJ, Carter DK, Fitzgibbons PL, et al. Protocol for the examination of specimens from patients with primary carcinomas of the colon and rectum. Arch Pathol Lab Med. 2009;133:1539-51.
- 5. Yildirim E, Berberoglu U. Lymph node ratio is more valuable than level III involvement for prediction of outcome in nodepositive breast carcinoma patients. World J Surg. 2007; 31:276-89.10.1007/s00268-006-0487-5
- 6. Marchet A, Mocellin S, Ambrosi A, de Manzoni G, Di Leo A, Marrelli D, et al. The prognostic value of N ratio in patients with gastric cancer: validation in a large, multicenter series. Eur J Surg Oncol. 2008; 34: 159-65.10.1016/j.ejso.2007.04.018
- 7. Herr H. Superiority of ratio based lymph node staging for bladder cancer. J Urol. 2003; 169:943-5.
- 8. Berger AC, Watson JC, Ross EA, Hoffman JP. The metastatic examined lymph node ratio is an important prognostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am Surg. 2004; 70: 235-40.
- 9. Berger AC, Sigurdson ER, LeVoyer T, Hanlon A, Mayer RJ, Macdonald JS, et al. Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Oncol. 2005; 23:8706-12.10.1200/JCO.2005.02.8852
- 10. De Ridder M, Vinh-Hung V, Van Nieuwenhove Y, Hoorens A, Sermeus A, Storme G. Prognostic value of the lymph node ratio in node positive colon cancer. Gut. 2006; 55:1681.10.1136/gut.2006.104117
- 11. Wang J, Hassett JM, Dayton MT, Kulaylat MN.L ymph node ratio: role in the staging of node-positive colon cancer. Ann Surg Oncol. 2008; 15:1600-8.10.1245/s10434-007-9716-x
- 12. Schumacher P, Dineen S, Barnett C Jr, Fleming J, Anthony T. The metastatic lymph node ratio predicts survival in colon cancer.AmJ Surg. 2007; 194:827-32.
- 13. Lee HY, Choi HJ, Park KJ, Shin JS, Kwon HC, Roh MS, et al. Prognostic significance of metastatic lymph node ratio in node positive colon carcinoma. Ann Surg Oncol. 2007; 14:1712-7.10.1245/s10434-006-9322-3
- 14. Klos CL, Bordeianou LG, Sylla P, Chang Y, Berger DL. The prognostic value of lymph node ratio after neoadjuvant chemoradiation and rectal cancer surgery. Dis Colon Rectum. 2011; 54:171-5.10.1007/DCR.0b013e3181fd677d
- 15. Moug SJ, Saldanha JD, McGregor JR, Balsitis M, Diament RH. Positive lymph node retrieval ratio optimises patient staging in colorectal cancer. Br J Cancer. 2009; 100:1530-3.10.1038/sj.bjc.6605049
- 16. Chang GJ, Rodriguez-Bigas MA, Skibber JM, Moyer VA. Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst. 2007; 99:433-41.10.1093/jnci/djk092
- 17. Baxter NN, Virnig DJ, Rothenberger DA, Morris AM, Jessurun J, Virnig BA. Lymph node evaluation in colorectal cancer patients: a population-based study. J Natl Cancer Inst. 2005; 97:219-25.10.1093/jnci/dji020